Taking together, these findings indicated that VEGF inhibition resulted in hypoxia and activated MET signaling enhancing the metastatic potential of HCC, and MET signaling inhibition attenuated the metastasis-promoting effects of HCC induced by VEGF inhibition. The gene discussed is MET; the disease is hepatocellular carcinoma.